Story · Medicine & Biotech
DNA Methylation Profiling May Predict Recurrence Risk in Uterine Cancer
1 outlet · first reported by Inside Precision Medicine on
Researchers at the University of California, San Francisco (UCSF) have identified an epigenetic signature that could help predict recurrence risk in patients with low-grade endometrioid adenocarcinoma whose tumors fall into the copy number low/non-specific molecular profile (CNL/NSMP) molecular… (Inside Precision Medicine)
Coverage, in order
-
DNA Methylation Profiling May Predict Recurrence Risk in Uterine Cancer
Researchers at the University of California, San Francisco (UCSF) have identified an epigenetic signature that could help predict recurrence risk in patients with low-grade endometrioid adenocarcinoma whose tumors fall into the copy number low/non-specific molecular profile (CNL/NSMP) molecular…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.